Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE frowns on Botox for headache prevention

February 16, 2012
Sales and Marketing Allergan, Botox, EMA, NHS, NICE

NICE is not recommending Allergan’s Botox for headache prevention, and has asked the firm for more information on the drug.  …

News

Amgen appoints Michael Severino as senior vice president, Global Development and Corporate chief medical officer

February 16, 2012
Business Services, Research and Development, Sales and Marketing

Michael Severino has been named senior vice president, Global Development and Corporate chief medical officer at Amgen.Severino, 46, formerly vice president, …

Appointment
Teva image

Teva launches generic Aricept in the UK

February 16, 2012
Manufacturing and Production, Sales and Marketing Alzheimer's, Aricept, NHS, Pfizer, Teva

Teva has launched its generic version of Alzheimer’s drug Aricept, as the drug loses its patent protection in the UK.  …

News

Emerging markets no haven from HTA, says NICE

February 15, 2012
Andrew Witty, GSK, NICE, NICE International

The head of NICE says pharma will face health technology assessment barriers in every country – including fast-growing developing markets. …

News

Most patients happy with hospital care

February 15, 2012
Sales and Marketing NHS, hospital, patient survey

A new survey has found that the vast majority of NHS patients receiving outpatient hospital care are happy with the …

News
Pfizer picture

FDA accepts Pfizer rare disease drug for review

February 15, 2012
Sales and Marketing EMA, FDA, FoldRx, Pfizer, tafamidis meglumine

The FDA has accepted for review Pfizer’s new drug to treat a rare neurodegenerative disease. Pfizer is seeking a licence …

News
Novo Nordisk image

Diabetes – the battle for control

February 15, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Novo Nordisk, Sanofi, Victoza, degludec, diabetes

This year marks the 90th anniversary of the first ever successful use of insulin to treat patients with type I …

Feature

Strategic North appoints Paula Lashley as consultant

February 15, 2012
Business Services, Medical Communications, Sales and Marketing

Healthcare strategic marketing consultancy Strategic North, who recently reached the final of the Manchester Evening News Business of the Year …

Appointment

New categories for IPA Best of Health Awards

February 15, 2012
Medical Communications Best of Health, IPA

This year’s IPA Best of Health Awards are now open for entries from healthcare advertising agencies worldwide. The annual awards …

News

Pharma critical of Obama budget

February 15, 2012
Research and Development, Sales and Marketing IPAB, Independent Payment Advisory Board, Medicare, Obama, PhRMA, US, healthcare reform

President Obama has unveiled a new budget which aims to cut the US deficit by $4 trillion over the next …

News
Twitter logo

Watchdog frowns on Botox tweet

February 15, 2012
Medical Communications Allergan, Chugai, PMCPA, Twitter

Allergan have been found in breach of the UK Code of Practice after an employee used Twitter to communicate about …

News

Market access: Communicating the story effectively

February 15, 2012
Medical Communications

By Andy Buckland – Principal Medical Writer at Abacus International  Successful market access relies on a multitude of activities throughout …

Feature
Thought Leadership
Biogen image

Biogen to pay $563 million for Stromedix

February 15, 2012
Research and Development, Sales and Marketing Bioden Idec, R&D, STX-100, Stromedix

Biogen Idec will acquire the specialist immunology firm Stromedix for around $500 million. Biogen currently focuses on the development of …

News

Ablynx appoints Dr Andreas Menrad as its new chief scientific officer

February 15, 2012
Business Services, Research and Development, Sales and Marketing Abllynx, Menrad, nanobody

Dr Andreas Menrad has joined the Belgium-based firm Ablynx as its new chief scientific officer. Dr Menrad has over 20 …

Appointment

New PV Legislation Implementation Plan by the European Medicines Agency

February 14, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing wainwright associates; Pharmacovigilance legislation

The European Medicines Agency has released an implementation plan for the pharmacovigilance legislation, which sets out milestone dates for different …

News
Press release

Virgo bolsters specialist value and access service

February 14, 2012
Medical Communications Jo Jones, NHS, Virgo, Virgo Health Communications

Virgo Health Communications has expanded its UK value and access expertise with the appointment of Tristan Mulholland.Tristan joins as Account …

News

Merck’s eye drug Zioptan gains FDA approval

February 14, 2012
Sales and Marketing Merck, Pfizer, Xalatan, Zioptan

The FDA has approved Merck’s eye solution Zioptan to treat a common eye condition. Zioptan (tafluprost ophthalmic solution) can now …

News

Premier Research appoints Sean Russell vice president, Marketing

February 14, 2012
Research and Development, Sales and Marketing Premier Research, Quintiles, Sean Russell

Premier Research Group has announced the appointment of Sean Russell to the position of vice president, marketing.In this position, Russell …

Appointment
Herceptin and Tyverb image

NICE cannot recommend breast cancer drugs

February 14, 2012
Sales and Marketing GSK, Herceptin, NHS, NICE, Roche, Tyverb

NICE is not recommending GlaxoSmithKline’s Tyverb or Roche’s Herceptin for use in certain breast cancer patients. The watchdog said in …

News
Shire picture

Robust sales for Shire

February 13, 2012
Sales and Marketing Replagal, Shire, Vpriv, Vyvanse

A rise in the use of attention deficit and hyperactivity disorder drugs has helped push Shire’s turnover past $4 billion …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026